MTEM Stock Summary and Trading Ideas (Molecular Templates | NASDAQ:MTEM)

Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.

Molecular Templates trades on the NASDAQ stock market under the symbol MTEM.

As of December 13, 2024, MTEM stock price declined to $0.40 with 579,383 million shares trading.

MTEM has a beta of -0.25, meaning it tends to be less sensitive to market movements. MTEM has a correlation of 0.00 to the broad based SPY ETF.

MTEM has a market cap of $2.63 million. This is considered a Sub-Micro Cap stock.

Last quarter Molecular Templates reported $572,000 in Revenue and -$1.23 earnings per share. This beat revenue expectation by $142,000 and exceeded earnings estimates by $.21.

In the last 3 years, MTEM traded as high as $66.75 and as low as $.30.

The top ETF exchange traded funds that MTEM belongs to (by Net Assets): VXF.

MTEM has underperformed the market in the last year with a return of -89.5%, while the SPY ETF gained +29.9%. In the last 3 month period, MTEM fell short of the market, returning -66.4%, while SPY returned +7.8%. However, in the most recent 2 weeks MTEM has outperformed the stock market by returning +8.1%, while SPY returned +0.3%.

MTEM support price is $.35 and resistance is $.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MTEM shares will trade within this expected range on the day.